27 April 2006
(Figures in brackets refer to the same period of the previous year)
- Net sales amounted to SEK 20.9 (11.5) million, an improvement of SEK 9.4 million (+82%)
compared to the same period of the previous year.
- The operating result was SEK –0.1 (-7.2) million, an increase of SEK 7.1 million compared to
the same period of the previous year.
- The result after tax was SEK 0.1 (-6.9) million, up by SEK 7 million compared to the same
period of the previous year.
- Earnings per share were SEK 0.01 (–0.40).
- Cash flow for the period totalled SEK +1.7 million, an improvement of SEK 10.6 compared to
the same period of previous year. Cash and cash equivalents at 31 March 2006 amounted to
SEK 50.0 million.
Key events during the first quarter of 2006
- Agreement with Novartis
- Three agreements in the Far East
- Agreement with Forest Laboratories
- Agreement with Ferring Pharmaceuticals
- New patent in the USA
Key events after the end of the first quarter
- Agreement with Laboratoire Physcience